YONG OUNPRASEUTH: Open Payments
NPI 1427501451 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,744 in 100 payments from 13 companies in 2025. Trend: 2023 $2,125 · 2024 $2,125 · 2025 $4,744
Speaker / faculty: $2,475Food & beverage: $1,808Travel & lodging: $461
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $3,478 |
| Gilead Sciences, Inc. | 14 | $299 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $207 |
| GENZYME CORPORATION | 9 | $191 |
| Ipsen Biopharmaceuticals, Inc | 10 | $150 |
| Stryker Corporation | 1 | $121 |
| Janssen Biotech, Inc. | 5 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| PFIZER INC. | 3 | $55 |
| QOL Medical, LLC | 1 | $25 |
Products named: MAVYRET, DUPIXENT, RINVOQ, IQIRVO, XIFAXAN, FLOWTRIEVER, LINZESS, TREMFYA.
Industry payments across AR — which companies pay providers there.
